Study Reveals Short Term Safety of Active Monitoring for DCIS
CPH welcomes Opeyemi Olabisi
The Center for Precision Health has welcomed Opeyemi Olabisi, MD, PhD, associate professor of medicine.
Olabisi's research focuses on APOL1 variants that contribute to the progression of kidney disease. His ultimate goal is to translate his findings into improved diagnostic and treatment approaches for chronic kidney disease.
As a clinician, Olabisi cares for individuals with various degrees of kidney disease. He is passionate about raising awareness about kidney disease and introduce remedies that could slow the progression of kidney disease.
Duke-Led Model Identifies Pathogenic Variants in Cardiac Patients, Offers Diagnostic Hope
Currently, many patients receive inconclusive results from genetic testing, leaving them without a clear diagnosis or a path forward for treatment, but a new model developed by researchers at Duke University could help increase the number of patients receiving positive test results, providing them with valuable information that could guide treatment decisions. Results were published in Circulation: Genomic and Precision Medicine.
Duke Center for Precision Health Awards Pilot Funding to Advance Genomic Science
The Duke Center for Precision Health and Precision Genomics Collaboratory have awarded five pilot grants to advance genomic science at Duke by leveraging and enhancing the OneDukeGen study infrastructure. This opportunity was open to all Duke University School of Medicine faculty.
Engineering Health: A Duke Patient’s Impact on Genomics and the Future of Medicine
Shaping the Future of Anesthesiology: Faculty Spotlight
Lori Orlando Part of New NIH-funded Genomics Initiative Award
Links Between Health and Place in Durham
Center for Precision Health Leader Pens Editorial for JAMA Cardiology
Improving the Odds: Using pharmacogenetic testing for treating depression
More than one in five people in the United States live with a mental illness, according to the National Institutes of Health. With several available drugs on the market for some of these conditions, like depression, it can be challenging to know what prescription will work best for individual patients. Oftentimes, though, these drugs take several weeks to feel the full effect, leaving patients in a state of limbo as they wait to see if their medication will work and provide them with relief or if they will need to try something else.